Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Language
Publication year range
1.
Sci Rep ; 8(1): 13195, 2018 09 04.
Article in English | MEDLINE | ID: mdl-30181567

ABSTRACT

Detecting covert consciousness in behaviorally unresponsive patients by brain imaging is of great interest, but a reproducible model and evidence from independent sources is still lacking. Here we demonstrate the possibility of using general anesthetics in a within-subjects study design to test methods or statistical paradigms of assessing covert consciousness. Using noninvasive neuroimaging in healthy volunteers, we identified a healthy study participant who was able to exhibit the specific fMRI signatures of volitional mental imagery while behaviorally unresponsive due to sedation with propofol. Our findings reveal a novel model that may accelerate the development of new approaches to reproducibly detect covert consciousness, which is difficult to achieve in patients with heterogeneous and sometimes clinically unstable neuropathology.


Subject(s)
Brain/drug effects , Brain/physiology , Consciousness/drug effects , Hypnotics and Sedatives/pharmacology , Propofol/pharmacology , Adult , Anesthetics, Intravenous/pharmacology , Brain/diagnostic imaging , Brain Mapping , Female , Humans , Magnetic Resonance Imaging , Male , Neuroimaging , Young Adult
2.
J Clin Neurosci ; 21(3): 526-9, 2014 Mar.
Article in English | MEDLINE | ID: mdl-24134809

ABSTRACT

The use of thrombolytics delivered through an external ventricular drain has improved outcomes in intraventricular hemorrhage, a disease with a poor prognosis; however, presence of an arteriovenous malformation is generally considered a contraindication to thrombolytic use. Due do the high mortality with the current standard of care, thrombolytics should be considered as an acceptable treatment option despite the presence of an arteriovenous malformation in certain clinical situations. We review the available literature and present an additional patient to make the case for the use of thrombolytics for intraventricular hemorrhage from an arteriovenous malformation.


Subject(s)
Cerebral Hemorrhage/drug therapy , Cerebral Hemorrhage/etiology , Fibrinolytic Agents/administration & dosage , Intracranial Arteriovenous Malformations/complications , Thrombolytic Therapy/methods , Tissue Plasminogen Activator/administration & dosage , Female , Humans , Infusions, Intraventricular , Young Adult
SELECTION OF CITATIONS
SEARCH DETAIL
...